Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies.

Go back to Resources

Comparison of unique leucovorin and 5-fluorouracil "escalating" and "maximum" dosage strategies.

Authors:

Secondary:

Pagination:

Issue:

PMID:

Keywords:

Abstract:

Go back to Resources

Clinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab.

Go back to Resources

Clinical trials referral resource: Current clinical trials of the anti-VEGF monoclonal antibody bevacizumab.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Breast cancer and prostate cancer.

Go back to Resources

Clinical trials referral resource. Breast cancer and prostate cancer.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial.

Go back to Resources

Biofeedback/relaxation training and exercise interventions for fibromyalgia: a prospective trial.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Clinical Trials Referral Resource: Mycosis Fungoides/Sézary Syndrome.

Go back to Resources

Clinical Trials Referral Resource: Mycosis Fungoides/Sézary Syndrome.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Trials of topotecan.

Go back to Resources

Clinical trials referral resource. Trials of topotecan.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Clinical trials referral resource. Prostate cancer II.

Go back to Resources

Clinical trials referral resource. Prostate cancer II.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Go back to Resources

Relationship between underlying renal disease and renal transplantation outcome.

Go back to Resources

Relationship between underlying renal disease and renal transplantation outcome.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Abstract:

Go back to Resources

Postoperative hypersensitivity in class I resin-based composite restorations in general practice: interim results.

Go back to Resources

Postoperative hypersensitivity in class I resin-based composite restorations in general practice: interim results.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

Keywords:

Abstract:

Go back to Resources

Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.

Go back to Resources

Leukemia after adjuvant chemotherapy with semustine (methyl-CCNU)--evidence of a dose-response effect.

Authors:

Secondary:

Volume:

Pagination:

Issue:

PMID:

DOI:

Keywords:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 51
  • Page 52
  • Page 53
  • Page 54
  • Current page 55
  • Page 56
  • Page 57
  • Page 58
  • Page 59
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification